Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_assertion type Assertion NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_head.
- NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_assertion description "[Expression of dominant-negative PPARgamma reverses transcriptional activation of 15-lipoxygenase-2 promoter by enhancing it 202-fold in normal prostate epithelial cells or suppressing it in prostate carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_provenance.
- NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_assertion evidence source_evidence_literature NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_provenance.
- NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_assertion SIO_000772 16682954 NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_provenance.
- NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_assertion wasDerivedFrom lhgdn-20090331 NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_provenance.
- NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_assertion wasGeneratedBy ECO_0000203 NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_provenance.